We found that overexpression of CSMD1 in glioma cells resulted in a decrease in phosphorylation of both P65 and STAT3 as well as a decrease in secretion of both IL-6 and IL-8 when compared to the corresponding Ctrl glioma cells. This evidence concerns the gene CSMD1 and central nervous system cancer.